Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Swiecie – page 28

925 clinical trials in Swiecie, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Swiecie at a glance
925
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

925 trials in Swiecie

Open in trial search

Type 2 diabetes mellitus

Not yet recruiting

Phase 3 Study of Maridebart Cafraglutide versus Semaglutide as Add‑on to Metformin (± SGLT‑2 Inhibitor) in Adults with Type 2 Diabetes Not Controlled by Metformin

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Amgen Inc.

Dementia Alzheimer's type

Not yet recruiting

Study on the Effects of AD04 and Placebo in Patients with Early Alzheimer's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Aluminium Hydroxide
  • Sponsor:Advantage Therapeutics GmbH

Diabetic retinal oedema

Not yet recruiting

Efficacy and Safety of Intravitreal MK-8748 Compared with Aflibercept in Adults with Diabetic Macular Edema

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Merck Sharp & Dohme LLC

Cardiovascular disorder+2

Not yet recruiting

Phase III Study Evaluating Efficacy and Safety of Petrelintide in Participants with Overweight or Obesity and Established Cardiovascular Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:F. Hoffmann-La Roche AG

Phase 2 Study of Inhaled AGMB-447 and Salbutamol Sulfate in Adults with Idiopathic Pulmonary Fibrosis to Evaluate Lung Function, Safety and Tolerability

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:Agomab Spain S.L.

Urinary retention

Not yet recruiting

Study of Teverelix in Men After First Episode of Acute Urinary Retention to Assess Prostate Size and Urinary Function

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Teverelix
  • Sponsor:Antev Limited

Rheumatoid arthritis

Not yet recruiting

Efficacy and safety of subcutaneous infliximab in patients with moderate to severe rheumatoid arthritis on background drug combination

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Folic Acid
  • Sponsor:Celltrion Inc.

Multiple sclerosis

Not yet recruiting

Long‑Term Safety and Tolerability of Frexalimab Drug Combination in Adults with Multiple Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Colestyramine
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Breast cancer+2

Not yet recruiting

Gedatolisib with drug combination versus standard therapy as first‑line treatment for patients with advanced HR‑positive HER2‑negative breast cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Celcuity Inc.

Dermatitis atopic

Not yet recruiting

Study of the safety and effectiveness of TRIV-573 injections in adults with moderate to severe atopic dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Triveni Bio Inc.

Anaemia+1

Not yet recruiting

Study of Elritercept (TAK‑226) with Ruxolitinib vs Placebo in Patients with Myelofibrosis and Anemia on Ruxolitinib Therapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Elritercept
  • Sponsor:Takeda Development Center Americas Inc.

Secondary immunodeficiency

Not yet recruiting

Study of Human Normal Immunoglobulin in Adults with Secondary Immune Deficiency after CAR T‑cell or T‑cell Redirecting Therapy for Hematologic Malignancies

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:CSL Behring LLC

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Swiecie

What the registry says about research in the country

01 Nephrology & Cardiovascular

Innovative research focusing on chronic kidney disease combined with hypertension, evaluating a dual therapy approach using baxdrostat and dapagliflozin to improve patient outcomes.

  • Kidney Function Preservation
  • Blood Pressure Management
  • Cardiovascular Risk Reduction

Studies aim to assess treatment effectiveness in preventing kidney failure and cardiovascular complications.

02 Psychiatric Care

Groundbreaking research evaluating the long-term safety profile of iclepertin for individuals with schizophrenia, focusing on cognitive improvement outcomes.

  • Cognitive Function
  • Treatment Safety
  • Extended Care Protocols

Extended monitoring of treatment effects in patients who completed previous clinical trials.

03 Mood Disorders

Novel investigation into the potential benefits of low-dose aspirin as a complementary treatment for bipolar disorder, exploring new therapeutic approaches.

  • Treatment Enhancement
  • Symptom Management
  • Safety Assessment

Research focuses on evaluating the efficacy of combining conventional therapy with anti-inflammatory approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.